influenza virus rna polymerase

T-705RTP is a selective and GTP-competitive of influenza virus RNA polymerase(IC50 of 0.14 μM and a Ki of 1.52 μM), has potent anti-influenza virus activity.

Baloxavir (S-033447) 是衍生自前药 Baloxavir marboxil，是流感病毒聚合酶 PA 亚基的一流帽依赖性核酸内切酶抑制剂。它抑制病毒 RNA 的转录和复制，具有强大的抗病毒活性。

Favipiravir 是一种有效且选择性的 RNA 依赖性 RNA 聚合酶抑制剂，用于治疗流感病毒感染。

T-705RTP sodium is a selective and GTP-competitive of influenza virus RNA polymerase(IC50 of 0.14 μM and a Ki of 1.52 μM), has potent anti-influenza virus activity.

Cynaroside (Luteolin 7-O-Glucoside) 是一个抗氧化类黄酮。它还是一种流感依赖 RNA 的RNA 聚合酶抑制剂，IC50为 32 nM。

Ribavirin-13C5 is intended for use as an internal standard for the quantification of ribavirin by GC- or LC-MS. Ribavirin (T0684) is an antiviral guanosine nucleoside analog.1,2Upon entry into cells,ribavirin is metabolized to an active triphosphate form that induces viral RNA chain termination and inhibits viral polymerases. It reduces replication in a panel of seven RNA and four DNA viruses in Vero cells (EC50s = 2-95 μg/ml).3Ribavirin also reduces replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)in Vero cells (EC50= 109.5 μM).4Aerosol administration of ribavirin (30 mg/kg)reduces mortality in a mouse model of influenza A infection.5Formulations containing ribavirin have been used in the treatment of respiratory syncytial virus (RSV),hepatitis C virus (HCV),and viral hemorrhagic fevers.

RdRP-IN-4 (compound 11q) 是一种芳基苯甲酰肼类似物，是一种口服具有活力的甲型流感病毒 RNA 依赖性 RNA 聚合酶 (RdRp) 抑制剂，能够直接结合 RdRp 的 PB1 亚基。RdRP-IN-4 可有效抑制 H5N1 禽流感病毒株，在 MDCK 细胞的 EC50=18 nM。RdRP-IN-4 对 H1N1 (A/PR/8/34) Flu A 株和 Flu B 株 (B/Lee/1940) 具有抑制作用，其 EC50 值分别为 53 nM 和 20 nM。RdRP-IN-4 以剂量依赖性方式显著抑制病毒核蛋白 (NP) 的表达水平。RdRP-IN-4 在受感染的小鼠中具有明显的抗病毒作用。

Cap-dependent endonuclease-IN-19 是一种螺环吡啶酮衍生物，是一种 cap-dependent 核酸内切酶 (CEN) 的有效抑制剂。Cap-dependent endonuclease-IN-19 能够强效的抑制甲型流感病毒的 RNA 聚合酶活性。

Cap-dependent endonuclease-IN-2 是一种 cap-dependent 核酸内切酶 (CEN) 的有效抑制剂。Cap-dependent endonuclease-IN-2 对流感病毒具有很好的抑制作用，且细胞毒性较低，具有较好的体内药剂动力学特性和体内药效学特性。Cap-dependent endonuclease-IN-2 能够明显的抑制甲型流感病毒 RNA 聚合酶活性。

Pimodivir, also known as VX-787, JNJ-872, is a novel inhibitor of influenza virus replication that blocks the PB2 cap-snatching activity of the influenza viral polymerase complex. VX-787 binds the cap-binding domain of the PB2 subunit with a KD (dissociation constant) of 24 nM as determined by isothermal titration calorimetry (ITC). The cell-based EC50 (the concentration of compound that ensures 50% cell viability of an uninfected control) for VX-787 is 1.6 nM in a cytopathic effect (CPE) assay, with a similar EC50 in a viral RNA replication assay. VX-787 is active against a diverse panel of influenza A virus strains, including H1N1pdm09 and H5N1 strains, as well as strains with reduced susceptibility to neuraminidase inhibitors (NAIs).

Favipiravir sodium is a selective inhibitor of viral RNA-dependent RNA polymerase with activity against many RNA viruses, influenza viruses, West Nile virus, yellow fever virus, foot-and-mouth disease virus as well as other flaviviruses, arenaviruses, bunyaviruses and alphaviruses.

trans-RdRP-IN-5 是一种有效的流感病毒 RNA 依赖性 RNA 聚合酶 (RdRP) 抑制剂。trans-RdRP-IN-5 可用于流感病毒的研究。

cis-RdRP-IN-5 是一种有效的流感病毒 RNA 依赖性 RNA 聚合酶 (RdRP) 抑制剂。cis-RdRP-IN-5 可用于流感病毒的研究。

RdRP-IN-5 (compound 20) 为一种抑制流感病毒RNA依赖性RNA聚合酶(RdRP)的有效药物，适用于该病毒研究。

Viral polymerase-IN-1 hydrochloride 是一种 Gemcitabine 衍生物，有效抑制甲型和乙型流感病毒 (influenza) 感染，IC90值为 11.4-15.9 μM。Viral polymerase-IN-1 hydrochloride 对 SARS-CoV-2感染具有活性。Viral polymerase-IN-1 hydrochloride 通过影响细胞中的病毒 RNA 复制/转录来抑制流感病毒感染。

Baloxavir-D5是Baloxavir (T14495)的氘代物。Baloxavir (Baloxavir acid）来源于前体Baloxavir marboxil，是一种针对甲型和乙型流感病毒聚合酶PA亚基内的首创帽依赖性核酸内切酶 (CEN)抑制剂。Baloxavir通过抑制病毒RNA的转录和复制展现出强大的抗病毒活性。